BISOLVON 8 mg, tablet 30 tablets
Active ingredients: Bromhexine hydrochloride
Commercialized according to BDPM
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BISOLVON 8 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- OPELLA HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2025
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61360073CIP73736061CIP133400937360616Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE BROMHEXINEcomprimé | 8,0 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.